Gritstone Bio Inc (NASDAQ:GRTS) traded at $0.81 at close of the session on Monday, April 29, made a downward move of -0.90% on its previous day’s price.
Looking at the stock we see that its previous close was $0.81. In terms of its 52-week price range, GRTS has a high of $3.33 and a low of $0.67. The company’s stock has lost about -68.63% over that past 30 days.
Gritstone Bio Inc has a market cap of $85.77 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.32, with the EPS growth for the year raised at -$1.01 for 2024 and -$0.96 for next year. These figures represent 15.80% and 5.00% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $1.1 million, with a high of $3.12 million. The median projection represents growth adding up to -55.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $13.96 million, or -14.60% down from figures reported last year.
On the other hand, looking at the outlook for the GRTS stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -15.39% off its SMA20 and -56.34% from its 50-day simple moving average. The RSI (14) is pointing at 30.97 while the volatility over the past week is 8.92% and jumps to 11.18% over the past one month. The beta value is 0.60, while the average true range (ATR) is currently pointing at 0.14.
Coming back to Gritstone Bio Inc (NASDAQ:GRTS), we note that the average 3-month trading volume was 2.88 million. Current shares outstanding are 97.59 million.
The insiders hold 8.58% of the company’s shares while institutions hold 35.45%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -60.49% down in year-to-date price movement.
